Astrazeneca UK LTD.
Research-based BioPharmaceutical Company
AI Overview
With $180K in lobbying spend across 8 quarterly filings, Astrazeneca UK LTD is an active lobbying client. Their lobbying covers 1 issue area. Active from 2022 to 2023.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $180K |
| 2023 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Astrazeneca UK LTD. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Environment
Educating and advocating on issues related to AstraZenecas efforts to substitute a non-global warming gas as the propellant in its metered dose inhalers.
Seeking consideration of AstraZeneca's intention to substitute zero Global Warming Potential (GWP) gases for current propellants in its metered dose inhalers.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.